Suppr超能文献

生物物理过程在淀粉样蛋白聚集中的交叉成核作用及其在淀粉样蛋白病理学中的意义。

Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology.

机构信息

Neurology, University of Michigan, Ann Arbor, MI 48109, USA; Biophysics, University of Michigan, Ann Arbor, MI 48109, USA.

Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, Chungbuk 28119, South Korea.

出版信息

Biophys Chem. 2021 Feb;269:106507. doi: 10.1016/j.bpc.2020.106507. Epub 2020 Nov 19.

Abstract

Abnormal aggregation of proteins into filamentous aggregates commonly associates with many diseases, such as Alzheimer's disease, Parkinson's disease and type-2 diabetes. These filamentous aggregates, also known as amyloids, can propagate their abnormal structures to either the same precursor molecules (seeding) or other protein monomers (cross-seeding). Cross-seeding has been implicated in the abnormal protein aggregation and has been found to facilitate the formation of physiological amyloids. It has risen to be an exciting area of research with a high volume of published reports. In this review article, we focus on the biophysical processes underlying the cross-seeding for some of the most commonly studied amyloid proteins. Here we will discuss the relevant literature related to cross-seeded polymerization of amyloid-beta, human islet amyloid polypeptide (hIAPP, or also known as amylin) and alpha-synuclein. SEVI (semen-derived enhancer of viral infection) amyloid formation by the cross-seeding between the bacterial curli protein and PAP is also briefly discussed.

摘要

蛋白质异常聚集形成纤维状聚集体通常与许多疾病有关,如阿尔茨海默病、帕金森病和 2 型糖尿病。这些纤维状聚集体,也称为淀粉样蛋白,可以将其异常结构传播到相同的前体分子(引发)或其他蛋白质单体(交叉引发)。交叉引发与异常蛋白质聚集有关,并已被发现有助于生理淀粉样蛋白的形成。它已成为一个令人兴奋的研究领域,发表了大量的报告。在这篇综述文章中,我们专注于一些研究最广泛的淀粉样蛋白的交叉引发的生物物理过程。在这里,我们将讨论与淀粉样蛋白-β、人胰岛淀粉样多肽(hIAPP,也称为胰岛淀粉样多肽)和α-突触核蛋白的交叉引发聚合相关的文献。细菌卷曲蛋白和 PAP 之间的交叉引发导致 SEVI(精液衍生的病毒感染增强子)淀粉样蛋白形成也被简要讨论。

相似文献

1
Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology.
Biophys Chem. 2021 Feb;269:106507. doi: 10.1016/j.bpc.2020.106507. Epub 2020 Nov 19.
2
Fluorescence-Based Monitoring of Early-Stage Aggregation of Amyloid-β, Amylin Peptide, Tau, and α-Synuclein Proteins.
ACS Chem Neurosci. 2024 Sep 4;15(17):3113-3123. doi: 10.1021/acschemneuro.4c00097. Epub 2024 Aug 16.
4
Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth.
Int J Biol Macromol. 2024 Nov;279(Pt 1):135137. doi: 10.1016/j.ijbiomac.2024.135137. Epub 2024 Aug 27.
6
The amyloid state of proteins: A boon or bane?
Int J Biol Macromol. 2022 Mar 1;200:593-617. doi: 10.1016/j.ijbiomac.2022.01.115. Epub 2022 Jan 22.
7
Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins.
J Biol Chem. 2021 Jan-Jun;296:100358. doi: 10.1016/j.jbc.2021.100358. Epub 2021 Feb 2.
8
Multi-Targeting Macrocyclic Peptides as Nanomolar Inhibitors of Self- and Cross-Seeded Amyloid Self-Assembly of α-Synuclein.
Angew Chem Int Ed Engl. 2025 Apr 1;64(14):e202422834. doi: 10.1002/anie.202422834. Epub 2025 Jan 31.
10
Cross-Seeding Interaction between β-Amyloid and Human Islet Amyloid Polypeptide.
ACS Chem Neurosci. 2015 Oct 21;6(10):1759-68. doi: 10.1021/acschemneuro.5b00192. Epub 2015 Aug 17.

引用本文的文献

1
Unraveling α-synuclein and amylin co-aggregation: pathological insights and biomarker development for Parkinson's disease.
Theranostics. 2025 Jun 20;15(15):7409-7424. doi: 10.7150/thno.112396. eCollection 2025.
3
Amyloid-β modulates the phase separation and aggregation of α-synuclein.
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2501987122. doi: 10.1073/pnas.2501987122. Epub 2025 Jul 14.
4
Experimental methods for studying amyloid cross-interactions.
Protein Sci. 2025 Jun;34(6):e70151. doi: 10.1002/pro.70151.
5
The p3 peptides (Aβ) rapidly form amyloid fibrils that cross-seed with full-length Aβ.
Nat Commun. 2025 Feb 27;16(1):2040. doi: 10.1038/s41467-025-57341-4.
7
Liquid-liquid phase separation and conformational strains of -Synuclein: implications for Parkinson's disease pathogenesis.
Front Mol Neurosci. 2024 Oct 23;17:1494218. doi: 10.3389/fnmol.2024.1494218. eCollection 2024.
8
Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots.
Int J Mol Sci. 2024 Oct 8;25(19):10809. doi: 10.3390/ijms251910809.
9
Extraction of In-Cell β-Amyloid Fibrillar Aggregates for Studying Molecular-Level Structural Propagations Using Solid-State NMR Spectroscopy.
Biochemistry. 2024 Oct 15;63(20):2557-2564. doi: 10.1021/acs.biochem.4c00395. Epub 2024 Sep 30.
10
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosis.
Front Cell Neurosci. 2024 Aug 5;18:1426231. doi: 10.3389/fncel.2024.1426231. eCollection 2024.

本文引用的文献

1
SUMOylation in α-Synuclein Homeostasis and Pathology.
Front Aging Neurosci. 2020 Jun 25;12:167. doi: 10.3389/fnagi.2020.00167. eCollection 2020.
2
Protein droplets in systems of disordered homopeptides and the amyloid glass phase.
Phys Chem Chem Phys. 2020 Jul 21;22(27):15592-15599. doi: 10.1039/d0cp01635g. Epub 2020 Jul 2.
5
Structures of α-synuclein filaments from multiple system atrophy.
Nature. 2020 Sep;585(7825):464-469. doi: 10.1038/s41586-020-2317-6. Epub 2020 May 27.
7
The emerging role of α-synuclein truncation in aggregation and disease.
J Biol Chem. 2020 Jul 24;295(30):10224-10244. doi: 10.1074/jbc.REV120.011743. Epub 2020 May 18.
9
Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
Neurobiol Dis. 2020 Jul;141:104876. doi: 10.1016/j.nbd.2020.104876. Epub 2020 Apr 25.
10
Biological links between traumatic brain injury and Parkinson's disease.
Acta Neuropathol Commun. 2020 Apr 7;8(1):45. doi: 10.1186/s40478-020-00924-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验